Clinical Trials
11 trialsNCT07270263 2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA Recruiting
NCT05255003 2025-12-17
STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Ottawa Hospital Research Institute
Phase 4 Recruiting
NCT07189897 2025-10-08
Apixaban or Enoxaparin After Head and Neck Cancer Surgery
State University of New York - Upstate Medical University
Phase 4 Recruiting
NCT03244020 2025-10-03
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
Massachusetts General Hospital
Phase 4 Enrolling by invitation
NCT02744092 2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA Completed
NCT01583218 2023-08-07
APEX
Alexion Pharmaceuticals, Inc.
Phase 3 Completed
NCT04999176 2021-08-10
VALERIA
Science Valley Research Institute
Phase 3 Unknown
NCT02366871 2020-03-31
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
Phase 2 Completed
NCT01817257 2018-10-29
ALICAT
Cardiff University
Phase 2 Terminated
NCT01164046 2014-12-03
Longheva
University Medical Center Groningen
Phase 3 Terminated
NCT00723216 2010-04-05
Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery
Sanofi
Phase 3 Completed